These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study. Janeiro D, Portolés J, Tato AM, López-Sánchez P, Del Peso G, Rivera M, Castellano I, Fernández-Reyes MJ, Pérez-Gómez V, Ortega M, Martínez-Miguel P, Felipe C, Caparrós G, Ortiz A, Selgas R, Grupo Centro de Diálisis Peritoneal (GCDP). Perit Dial Int; 2015 Jun 16; 35(5):530-6. PubMed ID: 25292408 [Abstract] [Full Text] [Related]
7. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network). Sigogne M, Kanagaratnam L, Dupont V, Couchoud C, Verger C, Maheut H, Hazzan M, Halimi JM, Barbe C, Canivet E, Petrache A, Dramé M, Rieu P, Touré F. Nephrol Dial Transplant; 2018 Nov 01; 33(11):2020-2026. PubMed ID: 29361078 [Abstract] [Full Text] [Related]
15. Thrombotic microangiopathy in United States long-term dialysis patients. Perkins RM, Reynolds JC, Ahuja TS, Reid T, Agodoa LY, Bohen EM, Yuan CM, Abbott KC. Nephrol Dial Transplant; 2006 Jan 01; 21(1):191-6. PubMed ID: 16204286 [Abstract] [Full Text] [Related]
16. Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage. Gagnon-Sanschagrin P, Liang Y, Sanon M, Oberdhan D, Guérin A, Cloutier M. J Med Econ; 2021 Jan 01; 24(1):193-201. PubMed ID: 33464936 [Abstract] [Full Text] [Related]